160 related articles for article (PubMed ID: 38779359)
1. Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma.
Li G; Chen L; Bai H; Zhang L; Wang J; Li W
Precis Clin Med; 2024 Jun; 7(2):pbae011. PubMed ID: 38779359
[TBL] [Abstract][Full Text] [Related]
2. Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
Tuluhong D; Gao H; Li X; Wang L; Zhu Y; Xu C; Wang J; Li H; Li Q; Wang S
Exp Cell Res; 2023 Dec; 433(1):113805. PubMed ID: 37839786
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of Lung Squamous Cancer Target HMGCS1 Promotes Cellular Ferroptosis].
Ni Y; Yang Y; Zhang L
Zhongguo Fei Ai Za Zhi; 2024 May; 27(5):330-336. PubMed ID: 38880920
[TBL] [Abstract][Full Text] [Related]
4. Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling.
Ge H; Zhao Y; Shi X; Tan Z; Chi X; He M; Jiang G; Ji L; Li H
Thorac Cancer; 2019 Mar; 10(3):428-436. PubMed ID: 30734525
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
[TBL] [Abstract][Full Text] [Related]
6. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
[TBL] [Abstract][Full Text] [Related]
7. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling.
He L; Li H; Pan C; Hua Y; Peng J; Zhou Z; Zhao Y; Lin M
Cancer Commun (Lond); 2021 Aug; 41(8):726-746. PubMed ID: 34268906
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma.
Li J; Yang T; Wang Q; Li Y; Wu H; Zhang M; Qi H; Zhang H; Li J
Int J Biol Sci; 2022; 18(9):3576-3591. PubMed ID: 35813482
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of squalene epoxidase in squamous lung cancerous tissues and pericarcinoma tissues.
Zhang HY; Li HM; Yu Z; Yu XY; Guo K
Thorac Cancer; 2014 Jul; 5(4):275-80. PubMed ID: 26767013
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of STEAP3 in lung squamous cell carcinoma: Regulating EGFR to affect cell proliferation and ferroptosis.
Shi H; Lei S; Xiong L; Du S; Shi Y
Arch Biochem Biophys; 2024 Jan; 751():109842. PubMed ID: 38040224
[TBL] [Abstract][Full Text] [Related]
11. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro.
Zhao F; Huang Y; Zhang Y; Li X; Chen K; Long Y; Li F; Ma X
Mol Biol Rep; 2022 Jul; 49(7):6613-6621. PubMed ID: 35552960
[TBL] [Abstract][Full Text] [Related]
12. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
13. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
[TBL] [Abstract][Full Text] [Related]
14. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
Wen J; Zhang X; Wong CC; Zhang Y; Pan Y; Zhou Y; Cheung AH; Liu Y; Ji F; Kang X; Liu D; Yu J
Gut; 2024 May; ():. PubMed ID: 38744443
[TBL] [Abstract][Full Text] [Related]
15. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
Li C; Wang Y; Liu D; Wong CC; Coker OO; Zhang X; Liu C; Zhou Y; Liu Y; Kang W; To KF; Sung JJ; Yu J
Gut; 2022 Nov; 71(11):2253-2265. PubMed ID: 35232776
[TBL] [Abstract][Full Text] [Related]
16. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
[TBL] [Abstract][Full Text] [Related]
17. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling.
Zhang Z; Wu W; Jiao H; Chen Y; Ji X; Cao J; Yin F; Yin W
Br J Pharmacol; 2023 Jun; 180(12):1562-1581. PubMed ID: 36581319
[TBL] [Abstract][Full Text] [Related]
18. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
[TBL] [Abstract][Full Text] [Related]
19. Squalene synthase predicts poor prognosis in stage I-III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression.
Jiang H; Tang E; Chen Y; Liu H; Zhao Y; Lin M; He L
Cancer Sci; 2022 Mar; 113(3):971-985. PubMed ID: 34939274
[TBL] [Abstract][Full Text] [Related]
20. Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC.
Zhao X; Guo B; Sun W; Yu J; Cui L
Adv Sci (Weinh); 2023 Sep; 10(27):e2206878. PubMed ID: 37490552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
